Bifidobacterium Breve for Skin Health

Research suggests that Bifidobacterium breve may support skin health primarily through its influence on the gut-skin axis, with the most directly relevant evidence coming from a double-blind, placebo-controlled trial highlighted in a 2014 review, which found that women consuming B. breve strain Yakult alongside a prebiotic had lower blood levels of gut-derived phenols and experienced reduced skin dryness and disrupted keratinization compared to controls. A 2025 review further situates probiotic use within the broader context of skin aging, noting that oral and topical probiotic interventions have shown promise in improving hydration, elasticity, and wrinkle depth in clinical studies, though B. breve is not the sole focus of that literature. It is worth noting that several studies in the linked evidence base — including work on the breast milk microbiome, infant food allergy, skin DNA extraction methods, and cancer immunology — are neutral in direction and do not bear directly on skin health outcomes for B. breve, which limits the strength of conclusions that can be drawn. Overall, the evidence is preliminary and largely review-level in nature, and more targeted clinical trials isolating B. breve's specific contributions to skin health would be needed before firm conclusions can be made.